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Hepatocellular carcinoma (lICC) is an extremely difficult disease to manage and one of 
the ten most common cancers in Malaysia. However, the molecular mechanisms that 
contribute to tumour progression in hepatocarcinogenesis remain unknown. 
In recent years, the evidence that the Wnt signaling pathway may play a crucial role in 
the hepatocarcinogenesis represents a major breakthrough. Despite efforts made in this 
area of research, the relationship between the related genes ofWnt signaling pathway is 
still far from comprehensive. 
By e�ploying immunohistochemistry and DNA sequencing, some related proteins and 
genes of the Wnt signaling pathway were investigated in 23 paired HCC and adjacent 
liver specimens from a tertiary referral centre in Malaysia. 
The results showed that: 
III 
1 .  The overexpression of p53 ,  �-catenin, Akt, phosphorylated glycogen synthase kinase 
(phospho-GSK)-3�, cyclin D1 , cyclooxygenase(COX)-2 and Wnt-1 was found in 
26. 1 %, 56.5%, 52.2%, 52.2%, 52.2%, 26. 1  % and 8.7% ofHCC tissues, respectively, 
and 0, 39. 1 %, 65.2%, 26.1 %, 4.3%, 47.8%, 0 in non-cancerous surrounding tissues, 
respectively. The expression of �-catenin, phospho-GSK-3� and cyclin D1 in HCC 
tissues was higher than in surrounding tissues, respectively (all p<0.05). These 
results suggest that p53,  �-catenin, phospho-GSK-3 � and cyclin D1 may play a role 
in HCC from Malaysia. 
2. In non-cancerous liver tissues, there was a possible relationship between the 
overexpression of COX-2 and �-catenin, phospho-GSK-3� and �-catenin, Akt and 
phospho-GSK-3�, respectively (all p<0.05). 
3. In HCC tissues, there was a possible relationship between the expression of 
phospho-GSK-3 �  and p53 ,  cyclin D1 and p53 ,  �-catenin and p53 ,  respectively (all 
p<0.05). 
4. According to above findings, it is likely that the development of HCC involves the 
�-GSK-3 �, Akt-GSK-3�-cyclin D1 and COX-2-�catenin pathways which was 
mediated or not mediated by p53. In addition, our results also supported that Wnt 
signaling pathway was involved in hepatocarcinogenesis. 
5 .  The results of nucleotide sequencing showed that no mutations at codon 249 ofp53 
and at the four potential consensus GSK-3� phosphorylation sites of �-catenin were 
IV 
found. Thus, it is likely that the increased expression of p-catenin resulted from the 
overexpression ofphospho-GSK-3 � and COX-2. 
This study is the first one to demonstrate that the related genes of the Wnt signaling 
pathway are involved in the hepatocarcinogenesis in Malaysia 
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Abstrak tesis yang dikemukakan kepada Senat Universiti Putra Malaysia sebagai 
memenuhi keperluan untuk ijazah Doktor Falsafah 
GEN-GEN YANG BERKAITAN DENGAN LINTASAN ISYARAT "WNT" PADA 
BARAH HATI 
Oleh 
KECHEN BAN 
Oktober 2002 
Pengerusi: Profesor Madya Dr. Seow Beng Fong 
Fakulti: Perubatan dan Sains Kesihatan 
Barah hati merupakan satu penyakit yang amat sukar diubati dan adalah salah satu dari 
sepuluh barah yang sering dihidapi umum di Malaysia. Walaubagaimanapun, 
mekanisma-mekanisma molekul yang menyumbang kepada pertumbuhan barah hati 
masih belum diketahui. 
Dikebelakangan ini, bukti yang menunjukkan lintasan isyarat "Wnt" memainkan 
peranan dalam pertumbuhan barah hati telah menjadi satu penemuan yang mustahak. 
Walaupun banyak usaha telah diambil, hubungan antara gen-gen yang berkaitan dengan 
lintasan isyarat "Wnt" masih tidak jelas. 
Beberapa protein dan gen yang berkaitan dengan lintasan isyarat "Wnt" telah dikaj i  di 
dalam 23  pasang spesimen tisu barah hati dan tisu sekeliling dari pusat rujukan tertier 
Malaysia dengan penggunaan immunohistokimia dan penjujukan DNA 
VI 
Keputusan-keputusan yang diperolehi menunjukkan bahawa: 
1 .  Pengekspresan berlebihan bagi p53,  p-catenin, Akt, glikogen synthase kinase (fosfo­
GSK)-3P, eyelin D1, eyelooxygenase (COX)-2 dan Wnt-l yang didapati adalah 
sebanyak 26. 1 %, 56.5%, 52.2%, 52.2%, 52.2%, 26. 1 % dan 8 . 1  % masing-masing di 
tisu barah hati berbanding dengan 0, 39. 1 %, 65 .2%, 26. 1 %, 4.3%, 47.8% dan 0 di 
tisu sekeliling. Pengekspresan p-catenin, fosfo-GSK-3 p dan eyelin D1 di dalam tisu 
barah hati adalah lebih tinggi berbanding dengan tisu sekeliling (p<0.05). Keputusan 
ini mencadangkan bahawa p53, p-catenin, fosfo-GSK-3 p dan eyelin D1  memainkan 
peranan dalam barah hati di Malaysia. 
2. Di dalam tisu hati yang bukan barah, hubungan pengekspresan yang berlebihan 
wujud bagi pasangan gen-gen yang berikut: COX-2 dan p-catenin, fosfo-GSK-3 p  dan 
p-catenin serta Akt dan fosfo-GSK-3 p  (p<0.05). 
3 .  Di dalam tisu barah hati pula. hubungan pengekspresan yang berlebihan wujud bagi 
pasangan gen-gen yang berikut: fosfo-GSK-3 p  dan p53, eyelin D1 dan p53 serta p­
catenin dan p53 .  
4 .  Penemuan di  atas mekadangkan bahawa pertumbuhan barah hati melibatkan lintasan 
Akt-GSK-3 p, Akt-GSK-3p-eyelin D1  dan COX-2-p-catenin yang samada dipandu 
oleh p53.  Selain itu, keputusan yang diperolehi juga menyokong penglibatan lintasan 
isyarat "Wnt" dalam proses pertumbuhan barah hati. 
vn 
5. Keputusan penjujukan menunjukkan bahawa tiada mutasi yang berlaku pada kodon 
249 bagi p53 serta empat lokasi yang berpotensi bagi pemfosforilasi GSK-3� .  Oleh 
itu, peningkatan pengespresan �-catenin kemungkinan besar disebabkan oleh 
pengekspresan fosfo-GSK-3 �  dan COX-2 yang berlebihan. 
Kaj ian ini merupakan kajian yang pertama menunjukkan penglibatan gen-gen yang 
berkaitan dengan lintasan isyarat "Wnt" dalam pertumbuhan barah hati di Malaysia. 
vm 
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CHAPTER I 
INTRODUCTION 
Hepatocellular carcinoma (HCC) occurs at high frequencies in East Asia and 
sub-Saharan Africa, representing 4% of all malignant tumours, and is the seventh most 
frequent carcinoma in males and the ninth most frequent carcinoma in females (Buendia 
et a/., 1992; Ng et a/., 1994; Caselmann et a/., 1996). It has been estimated that there are 
1 million cases per year in the world. The major aetiologies of HCC include chronic 
infection with the hepatitis B virus (HBV) and hepatitis C virus (HCV) and exposure to 
the fungal toxin aflatoxin B1 (AFB1) (Hussain et a/., 2001). The rates ofHBV infection 
varies widely. In Nigeria, Benin and China including Taiwan, the incidence is high, 
while in the continental United States and in western Europe the incidence is relatively 
low. On the contrary, the prevalence of HCV antibody-positive patients with HCC was 
relatively higher in Japan, South Africa, Europe and USA (Edamato et al., 1996). 
In Malaysia, about 5% of healthy volunteers were positive for hepatitis B surface 
antigen (HBsAg) in 1997 (Merican et a/., 2000) and HCC is one of the ten most 
common cancers amongst the male population in this country (Merican, 1996). 
HCC is an extremely difficult disease to manage. The treatment modalities for 
HCC have made little progress in the past ten years. ·Moreover, recent reports showed 
that the incidence ofHCC is increasing in low to middle-incidence countries such as the 
USA, France, UK and most particularly, Japan (Anthony et aI., 2001). Therefore, it is 
important to elucidate the molecular mechanisms of hepatocarcinogenesis which 
remains unknown. 
It is believed that HCC is a disease of multiple modalities. So far, many signaling 
pathways have been implicated in hepatocarcinogenesis. 
In recent years, the evidence that the Wnt signaling pathway plays a crucial role 
in the hepatocarcinogenesis represents a major breakthrough (Buendia et a/., 2000). 
Intracellular protein complexes, including Dishevelled (DvllDsh), glycogen synthase 
kinase-3� (GSK-3�), axin and adenomatous polyposis coli (APC) protein, regulate 
cytosolic �-catenin protein levels. 
The �-catenin, like its homologue armadillo in Drosophila, is an important 
multifunctional protein involved in cell-cell adhesion, by strengthening the linkage of 
cadherin and a-catenin to the actin cytoskeleton (Aberle et a/., 1996). It is also involved 
in Wnt signaling during embryonic development (Cadigan et a/., 1997) and 
inappropriate reactivation of this pathway has been implicated in tumourigenesis. In the 
absence of Wnt signaling, �-catenin is phosphorylated at N-terminal serine-threonine 
residues by functional interactions with GSK-3�, axin and APC, and subsequently 
targeted to degradation by the ubiquitin-proteasome system (polak is et a/., 1997). 
Activation of the Wnt signal inhibits GSK-3� activity and induces �-catenin 
stabilization. Translocation of �-catenin to the nucleus and its association with high 
mobility group domain factors T cell factorllymphoid enhancer factor (TcffLEF) causes 
transcriptional activation of target genes (Clevers et a/., 1997). Recently, mutant �-
2 
catenins that are resistant to down-regulation by GSK- 3� phosphorylation and 
ubiquitination have been characterized in a variety of carcinomas (Morin et al., 1997, 
Iwao et al., 1998; Polakis et al., 1999). In colon cancers, immunohistochemical studies 
have demonstrated increased expression of �-catenin and its nuclear localization in 
tumours harboring either APC defects or �-catenin mutations in the GSK-3 � 
phosphorylation domain (Iwao et al., 1998; Inomata et al., 1996). Nuclear and 
cytoplasmic localization of �-catenin was also frequently seen in ovarian, uterine 
carcinomas and melanomas, although genetic alterations of the �-catenin gene could be 
detected only in a minority of these tumours (palacios et aI., 1998; Fukuchi et aI., 1998; 
Rimm et aI., 1999). 
In human HCC, mutations of the �-catenin gene have been reported in 19 to 41 % 
of primary tumours (de La Coste et al., 1998; Huang et aI., 1999). There were reports 
that the overexpression of B-catenin may be related to the proliferative activity and 
dedifferentiation ofHCC (An et al., 2001) and activation of the Wnt signaling pathway 
by �-catenin mutation contributes significantly to the hepatocellular carcinogenesis 
(Huang et al., 1999). 
Until June of 2002, the list of target genes of Wnt signaling covers 46 members 
(http://www.stanford.edu/-musse/pathways/targets.htrnl), including cyclin Dl (Tetsu et 
al., 1999; Shtutman et al., 1999) and Cyclooxygenase(COX)-2 (Howe et al., 1999; 
Haertel-Wiesmann et aI., 2000). 
Both cyclin Dl and COX-2 are believed to play a role in hepatocarcinogenesis. 
3 
Cyclin D 1 has been suggested to be rate-limiting for the progression from G1 
into S phase of the cell cycle, based on the observation that their constitutive 
overexpression leads to a shorter G1 phase (Ando et a/., 1993; Musgrove et a/., 1994). 
Constitutive overexpression of cyclin D 1 in mouse mammary glands leads to carcinoma, 
indicating that cyclin Dl acts as an oncogene (Wang et a/., 1994). Cyclin Dl have also 
been implicated in the development ofHCC (Deane et a/., 2001; Nishida et a/., 1994). 
Expression of COX-2 has been reported to be responsible for enhanced tumour 
growth and angiogenesis in various tumours (Sano et a/., 1995; Ristimaki et a/., 1997; 
Zimmermann et a/., 1999; Hida et aI., 1998), including HCC (Bae et aI., 2001; Rahman 
et a/., 2001; Kondo et a/., 1999; Shiota et a/., 1999; Koga et al., 1999). 
In recent years, some HCC-related genes have also been reported to be associated 
with the components or target genes ofWnt signaling pathway. 
Abnormalities of p53 are the most frequent genetic alterations in human cancers 
(Hollstein et a/., 1991). The p53 tumour suppressor gene plays a key role in human 
carcinogenesis through regulating its target genes involved in cell cycle control and 
apoptosis in response to cellular damage (Levine et a/., 1997). The p53 gene has also 
been shown to play an important role in hepatocarcinogenesis. p53 mutations have been 
found in about 25-45% ofHCCs (Montesano et a/., 1997). A unique mutation hotspot, a 
G to T transversion at the third base of codon 249 of the p53 gene was observed in the 
HCC tissues in the region with presumed high AFB 1 exposure (Wang et a/., 1999). The 
presence of p53 mutations was associated with a shortened (cancer-free) survival of 
4 
